(Q28565656)

English

Protease-resistant glucose-dependent insulinotropic polypeptide agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid

scientific journal article

In more languages

Statements

scholarly article

1 reference

PubMed publication ID

31 January 2017

Protease-resistant glucose-dependent insulinotropic polypeptide agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid (English)

1 reference

PubMed publication ID

31 January 2017

0 references

author name string

Victor A. Gault

1

1 reference

PubMed publication ID

31 January 2017

Christian Hölscher

2

1 reference

PubMed publication ID

31 January 2017

language of work or name

0 references

publication date

1 April 2008

1 reference

PubMed publication ID

31 January 2017

Journal of Neurophysiology

1 reference

PubMed publication ID

31 January 2017

99

1 reference

PubMed publication ID

31 January 2017

4

1 reference

PubMed publication ID

31 January 2017

1590–1595

1 reference

PubMed publication ID

31 January 2017

beta-Amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarized hippocampal slices.

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Inhibition of L-type voltage dependent calcium channels causes impairment of long-term potentiation in the hippocampal CA1 region in vivo

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo.

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background.

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Glucagon‐like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Cognition and synaptic plasticity in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid.

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Possible Causes of Alzheimer's Disease: Amyloid Fragments, Free Radicals, and Calcium Homeostasis

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Stable agonist of glucose-dependent insulinotropic polypeptide (GIP) restores pancreatic beta cell glucose responsiveness but not glucose intolerance in aging mice.

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

A novel, long-acting agonist of glucose-dependent insulinotropic polypeptide suitable for once-daily administration in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Increased risk of type 2 diabetes in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Common pathological processes in Alzheimer disease and type 2 diabetes: a review

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation.

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Immunohistochemical distribution of glucose-dependent insulinotropic polypeptide in the adult rat brain

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission

1 reference

https://api.crossref.org/works/10.1152%2FJN.01161.2007

21 January 2018

Identifiers

10.1152/JN.01161.2007

1 reference

PubMed publication ID

31 January 2017

PubMed publication ID

1 reference

PubMed publication ID

31 January 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28565656&oldid=1982683077"